Search

Albert T Derivan

from Villanova, PA
Age ~84
Get Report
Also known as:
Albert Thomas Derivan, Al T Derivan, Albert T Erivan, Albert T Dervian
Related to:
Lynn Brian Starling, 75Alicia A Newton, 27Nancy R Lynn, 60Donna A Derivan, 54Robert M Newton, 64Mary C Derivan, 85Kenneth J Lynn, 61Janice D Newton, 60Kevin Lynn
Connected to:
Steven A Derivan, 62Clara G Derivera, 53Joseph H Derivera, 92S R Derivera, 80Desiree L Derix, 48Alexander B Deriy, 39Jason P Derk, 50Elyssa A Derka, 32Lori A Derka, 50Alena Derkach, 86

Albert Derivan Phones & Addresses

  • Villanova, PA
  • 229 Paperbirch Dr, Collegeville, PA 19426 (610) 454-7721 (610) 454-7850
  • Newtown, PA
  • 42 Overlook Cir, Berwyn, PA 19312 (610) 722-0229 (610) 722-9075
  • Norristown, PA
  • Baltimore, MD
  • Montgomery, PA
  • Buck, PA
  • 229 Paperbirch Dr, Collegeville, PA 19426

Work

Position: Executive, Administrative, and Managerial Occupations

Education

Degree: Associate degree or higher

Emails

a***[email protected]

Professional Records

License Records

Albert Thomas Derivan

Address:
Collegeville, PA 19426
License #:
MD034282E - Expired
Category:
Medicine
Type:
Medical Physician and Surgeon

Medicine Doctors

Albert Derivan Photo 1

Albert Thomas Derivan

View page
Specialties:
Psychiatry
Child Psychiatry
Education:
UMDNJ (1966) *

Business Records

Name / Title
Company / Classification
Phones & Addresses
Albert T. Derivan
Child Psychology, Medical Doctor, Psychiatry
Dr. Albert T. Derivan, MD
Dentist's Office
229 Paperbirch Dr, Collegeville, PA 19426
Albert Thomas Derivan
Albert Derivan MD
Psychiatrist
229 Paperbirch Dr, Collegeville, PA 19426
(610) 454-7721
Albert T. Derivan
Psychiatry
Counseling Kelly & Consulting
Individual/Family Services
305 Vly Brooke Rd, Chester Heights, PA 19017
PO Box 534, Chester Heights, PA 19017
Albert Derivan
Executive Director
Jj Corporate
Whol Women's/Child's Clothing
920 Us Hwy 202, Raritan, NJ 08869
(908) 429-1893

Publications

Us Patents

Treatment Using Venlafaxine

View page
US Patent:
6444708, Sep 3, 2002
Filed:
Jan 25, 2001
Appl. No.:
09/769998
Inventors:
Richard L. Rudolph - Berwyn PA
Albert T. Derivan - Villanova PA
G. Virginia Upton - Radnor PA
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 31135
US Classification:
514649, 514653, 514654
Abstract:
This invention provides a method of treating obesity, generalized anxiety disorder, post-traumatic stress disorder, late luteal phase disphoric disorder (premenstrual syndrome), attention deficit disorder, with and without hyperactivity, Gilles de la Tourette syndrome, bulimia nervosa or Shy Drager Syndrome in a mammal by administering to the mammal an effective amount of a hydroxycycloalkanephenethyl amine of the following structural formula: in which A is a moiety of the formula where the dotted line represents optional unsaturation; R is hydrogen or alkyl; R is alkyl; R is hydrogen, alkyl, formyl, or alkanol; R and R are, independently, hydrogen, hydroxyl, alkyl, alkoxy, alkanoyloxy, cyano, nitro, alkylmercapto, amino, alkylamino, dialkylamino, alkanamido, halo, trifluoromethyl, or taken together, methylene dioxy; R is hydrogen or alkyl; and n is 0, 1, 2, 3, or 4; or a pharmaceutically acceptable salt thereof.

Treatments Using Venlafaxine

View page
US Patent:
6465524, Oct 15, 2002
Filed:
Jun 27, 2001
Appl. No.:
09/892363
Inventors:
Richard L. Rudolph - Berwyn PA
Albert T. Derivan - Villanova PA
Eric A. Muth - New Hope PA
G. Virginia Upton - Radnor PA
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 31135
US Classification:
514649, 514653, 514654
Abstract:
This invention provides a method of treating obesity, generalized anxiety disorder, post-traumatic stress disorder, late luteal phase disphoric disorder (premenstrual syndrome), attention deficit disorder, with and without hyperactivity, Gilles de la Tourette syndrome, bulimia nervosa or Shy Drager Syndrome in a mammal by administering to the mammal an effective amount of a hydroxycycloalkanephenethyl amine of the following structural formula: in which A is a moiety of the formula where the dotted line represents optional unsaturation; R is hydrogen or alkyl; R is alkyl; R is hydrogen, alkyl, formyl, or alkanol; R and R are, independently, hydrogen, hydroxyl, alkyl, alkoxy, alkanoyloxy, cyano, nitro, alkylmercapto, amino, alkylamino, dialkylamino, alkanamido, halo, trifluoromethyl, or taken together, methylene dioxy; R is hydrogen or alkyl; and n is 0, 1, 2, 3, or 4; or a pharmaceutically acceptable salt thereof.

Treatments Using Venlafaxine

View page
US Patent:
6555586, Apr 29, 2003
Filed:
Nov 30, 2001
Appl. No.:
09/996590
Inventors:
Richard L. Rudolph - Houston TX
Albert T. Derivan - Newtown PA
G. Virginia Upton - Vero Beach PA
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 31135
US Classification:
514649
Abstract:
This invention provides a method of treating obesity, generalized anxiety disorder, post-traumatic stress disorder, late luteal phase disphoric disorder (premenstrual syndrome), attention deficit disorder, with and without hyperactivity, Gilles de la Tourette syndrome, bulimia nervosa or Shy Drager Syndrome in a mammal by administering to the mammal an effective amount of a hydroxycycloalkanephenethyl amine of the following structural formula: in which A is a moiety of the formula where the dotted line represents optional unsaturation; R is hydrogen or alkyl; R is alkyl; R is hydrogen, alkyl, formyl, or alkanol; R and R are, independently, hydrogen, hydroxyl, alkyl, alkoxy, alkanoyloxy, cyano, nitro, alkylmercapto, amino, alkylamino, dialkylamino, alkanamido, halo, trifluoromethyl, or taken together, methylene dioxy; R is hydrogen or alkyl; and n is 0, 1, 2, 3, or 4; or a pharmaceutically acceptable salt thereof.

Treatments Using Venlafaxine

View page
US Patent:
20030181517, Sep 25, 2003
Filed:
Mar 25, 2003
Appl. No.:
10/396043
Inventors:
Richard Rudolph - Berwyn PA, US
Albert Derivan - Villanova PA, US
Eric Muth - New Hope PA, US
G. Upton - Radnor PA, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K031/335
A61K031/277
A61K031/24
A61K031/165
A61K031/137
US Classification:
514/467000, 514/524000, 514/649000, 514/540000, 514/620000
Abstract:
This invention provides a method of treating obesity, generalized anxiety disorder, post-traumatic stress disorder, late luteal phase dysphoric disorder (premenstrual syndrome), attention deficit disorder, with and without hyperactivity, Gilles de la Tourette syndrome, bulimia nervosa or Shy Drager Syndrome in a mammal by administering to the mammal an effective amount of a hydroxycycloalkanephenethyl amine of the following structural formula: in which A is a moiety of the formula where the dotted line represents optional unsaturation; Ris hydrogen or alkyl; Ris alkyl; Ris hydrogen, alkyl, formyl, or alkanol; Rand Rare, independently, hydrogen, hydroxyl, alkyl, alkoxy, alkanoyloxy, cyano, nitro, alkylmercapto, amino, alkylamino, dialkylamino, alkanamido, halo, trifluoromethyl, or taken together, methylene dioxy; Ris hydrogen or alkyl; and n is 0, 1, 2, 3, or 4; or a pharmaceutically acceptable salt thereof.

Treatments Using Venlafaxine

View page
US Patent:
20040110829, Jun 10, 2004
Filed:
Nov 25, 2003
Appl. No.:
10/721629
Inventors:
Richard Rudolph - Berwyn PA, US
Albert Derivan - Villanova PA, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K031/36
A61K031/277
A61K031/137
US Classification:
514/464000, 514/524000, 514/649000, 514/534000
Abstract:
This invention provides a method of treating obesity, generalized anxiety disorder, post-traumatic stress disorder, late luteal phase dysphoric disorder (premenstrual syndrome), attention deficit disorder, with and without hyperactivity, Gilles de la Tourette syndrome, bulimia nervosa or Shy Drager Syndrome in a mammal by administering to the mammal an effective amount of a hydroxycycloalkanephenethyl amine of the following structural formula: in which A is a moiety of the formula where the dotted line represents optional unsaturation; Ris hydrogen or alkyl; Ris alkyl; Ris hydrogen, alkyl, formyl, or alkanol; Rand Rare, independently, hydrogen, hydroxyl, alkyl, alkoxy, alkanoyloxy, cyano, nitro, alkylmercapto, amino, alkylamino, dialkylamino, alkanamido, halo, trifluoromethyl, or taken together, methylene dioxy; Ris hydrogen or alkyl; and n is 0, 1, 2, 3, or 4; or a pharmaceutically acceptable salt thereof.

Treatments Using Venlafaxine

View page
US Patent:
20080176950, Jul 24, 2008
Filed:
Aug 20, 2007
Appl. No.:
11/841636
Inventors:
Richard L. Rudolph - Berwyn PA, US
Albert T. Derivan - Villanova PA, US
Eric A. Murh - New Hope PA, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 31/137
US Classification:
514649
Abstract:
This; invention provides a method of treating obesity, generalized anxiety disorder, post-traumatic stress disorder, late luteal phase dysphoric disorder (premenstrual, syndrome), attention deficit disorder, with and without hyperactivity, Gilles de la Tourette syndrome, bulimia nervosa or Shy Drager Syndrome in a: mammal by administering to the mammal an effective amount of a hydroxycycloalkanephenethyl amine of the following structural formula:in which A is a moiety of the formulawhere

Treatments Using Venlafaxine

View page
US Patent:
63101017, Oct 30, 2001
Filed:
Apr 2, 1999
Appl. No.:
9/285812
Inventors:
Richard L. Rudolph - Berwyn PA
Albert T. Derivan - Villanova PA
Eric A. Muth - New Hope PA
G. Virginia Upton - Radnor PA
Assignee:
American Home Products Corporation - Madison NJ
International Classification:
A61K 31135
US Classification:
514649
Abstract:
This invention provides a method of treating obesity, generalized anxiety disorder, post-traumatic stress disorder, late luteal phase disphoric disorder (premenstrual syndrome), attention deficit disorder, with and without hyperactivity, Gilles de la Tourette syndrome, bulimia nervosa or Shy Drager Syndrome in a mammal by administering to the mammal an effective amount of a hydroxycycloalkanephenethyl amine of the following structural formula: ##STR1## in which A is a moiety of the formula ##STR2## where the dotted line represents optional unsaturation; R. sub. 1 is hydrogen or alkyl; R. sub. 2 is alkyl; R. sub. 4 is hydrogen, alkyl, formyl, or alkanol; R. sub. 5 and R. sub. 6 are, independently, hydrogen, hydroxyl, alkyl, alkoxy, alkanoyloxy, cyano, nitro, alkylmercapto, amino, alkylamino, dialkylamino, alkanamido, halo, trifluoromethyl, or taken together, methylene dioxy; R. sub. 7 is hydrogen or alkyl; and n is 0, 1, 2, 3, or 4; or a pharmaceutically acceptable salt thereof.

Venlafaxine In The Treatment Of Hypothalamic Amenorrhea In Non-Depressed Women

View page
US Patent:
55062709, Apr 9, 1996
Filed:
Jan 30, 1995
Appl. No.:
8/380903
Inventors:
Gertrude V. Upton - Radnor PA
Albert T. Derivan - Villanova PA
Richard L. Rudolph - Berwyn PA
Assignee:
American Home Products Corporation - Madison NJ
International Classification:
A61K 31045
A01N 3100
US Classification:
514730
Abstract:
This invention provides a method for treating hypothalamic amenorrhea in a non-depressed female mammal by administering to the mammal an effective amount of a hydroxycycloalkanephenethyl amine compound of the following structural formula: ##STR1## in which A is a moiety of the formula ##STR2## wherein the dotted line represents optional unsaturation; R. sub. 1 is hydrogen or alkyl; R. sub. 2 is alkyl; R. sub. 4 is hydrogen, alkyl, formyl, or alkanol; R. sub. 5 and R. sub. 6 are, independently, hydrogen, hydroxyl, alkyl, alkoxy, alkanoyloxy, cyano, nitro, alkylmercapto, amino, alkylamino, dialkylamino, alkanamido, halo, trifluoromethyl, or taken together, methylene dioxy; R. sub. 7 is hydrogen or alkyl; and n is 0, 1, 2, 3, or 4; or a pharmaceutically acceptable salt thereof.
Control profile
Albert T Derivan from Villanova, PA, age ~84 Get Report